scholarly journals Supraglottiskarzinom: Erfahrungen mit der transoralen Roboter-Chirurgie

2019 ◽  
Vol 98 (03) ◽  
pp. 143-144
Author(s):  
Markus Kapsreiter

Karabulut B et al. Comparison of functional and oncological treatment outcomes after transoral robotic surgery and open surgery for supraglottic laryngeal cancer. J Laryngol Otol 2018; 132: 832–836 Die Behandlungsmöglichkeiten eines Supraglottiskarzinoms umfassen offene Supraglottis-Laryngektomie, transorale Lasertherapie, transorale Roboterchirurgie und Chemotherapie. Ärzte der HNO-Klinik des Ümraniye-Krankenhauses in Istanbul verglichen die Behandlungsergebnisse bei Patienten mit supraglottischen Tumoren des Larynxkarzinoms, die mittels einer transoralen robotischen Laryngektomie und einer offenen Laryngektomie behandelt wurden.

2018 ◽  
Vol 132 (9) ◽  
pp. 832-836 ◽  
Author(s):  
B Karabulut ◽  
İ Deveci ◽  
M Sürmeli ◽  
A Şahin-Yilmaz ◽  
Ç Oysu

AbstractObjectiveTo compare functional and oncological treatment outcomes among patients with supraglottic laryngeal cancers who underwent transoral robotic supraglottic laryngectomy and open supraglottic laryngectomy.MethodsA retrospective chart review was conducted of 17 patients treated by transoral robotic supraglottic laryngectomy and 20 patients treated by open supraglottic laryngectomy.ResultsNo tracheostomy or prolonged intubation was needed in the transoral robotic surgery group. Furthermore, that group had a shorter oral feeding time, hospitalisation and recovery period. There was no difference between groups in terms of complications. There were no differences in overall survival time and disease-specific survival time between groups.ConclusionTransoral robotic supraglottic laryngectomy for supraglottic laryngeal cancer is an oncologically safe and functional procedure with better results when compared to conventional open surgery.


2013 ◽  
Vol 123 (3) ◽  
pp. 635-640 ◽  
Author(s):  
Harry Quon ◽  
Marc A. Cohen ◽  
Kathleen T. Montone ◽  
Amy F. Ziober ◽  
Li Ping Wang ◽  
...  

2017 ◽  
Vol 68 (2) ◽  
pp. 122-125
Author(s):  
Y. Kishimoto ◽  
I. Tateya ◽  
A. Shimizu ◽  
K. Fujiwara ◽  
K. Tsukahara ◽  
...  

Author(s):  
À. Roselló ◽  
R. Albuquerque ◽  
X. Roselló-Llabrés ◽  
A. Marí-Roig ◽  
A. Estrugo-Devesa ◽  
...  

2015 ◽  
Vol 139 (11) ◽  
pp. 1389-1397 ◽  
Author(s):  
Samuel N. Helman ◽  
Thomas Schwedhelm ◽  
Sameep Kadakia ◽  
Yanhua Wang ◽  
Bradley A. Schiff ◽  
...  

Context The incidence of oropharyngeal squamous cell carcinoma has increased during the past decade and is related primarily to the human papillomavirus. This change in etiology, from tobacco and alcohol to human papillomavirus, has resulted in improved survival for the disease. In the United States, open resection had largely been replaced by concurrent chemotherapy and/or radiotherapy by the early 2000s. The advent of transoral surgery has led to an increase in surgery as the primary treatment for both early- and advanced-stage oropharyngeal squamous cell carcinoma because it has potential advantages over open surgery and nonsurgical modalities. Objective To provide an overview of transoral robotic surgery for oropharyngeal squamous cell carcinoma and contrast it with other surgical and nonsurgical modalities. Data Sources Articles from 2000 to 2014 were accessioned on PubMed and reviewed for utility by the primary authors. Conclusions Transoral surgery has become more commonly used as a minimally invasive approach to treat oropharyngeal tumors. Other strategies, including radiation, chemotherapy with radiation, and open surgery, are still important treatment approaches. The treatment options for an individual patient rely on multiple factors, including the tumor location and size, features of the tumor, and patient comorbidities. The continued study of these techniques is important to match the patient with the most appropriate treatment.


Sign in / Sign up

Export Citation Format

Share Document